Protein Aggregation in the Pathogenesis of Ischemic Stroke

Area of Science:

• Neuroscience
• Pathophysiology
• Molecular Biology

Background:

• Ischemic stroke and neurodegenerative diseases share inflammatory and oxidative stress pathways.
• Protein aggregation is a hallmark of neurodegenerative diseases but also occurs after cerebral ischemia.
• This protein aggregation exacerbates ischemic brain injury, highlighting a molecular overlap.

Purpose of the Study:

• To review the current understanding of protein aggregation in ischemic stroke.
• To explore the role of protein aggregation in aggravating cerebral ischemic injury.
• To identify knowledge gaps regarding the mechanisms and prevention of post-ischemic protein aggregation.

Main Methods:

• Literature review of studies on protein aggregation in cerebral ischemia and neurodegenerative diseases.
• Analysis of the molecular mechanisms linking inflammation, oxidative stress, and protein aggregation.
• Synthesis of current findings on the impact of protein aggregation on ischemic stroke outcomes.

Main Results:

• Protein aggregation is induced rapidly after cerebral ischemia, contributing significantly to brain damage.
• Shared pathophysiological mechanisms, including inflammation and oxidative stress, link stroke and neurodegeneration.
• The precise mechanisms driving protein aggregation post-ischemia and strategies for its prevention require further investigation.

Conclusions:

• Protein aggregation represents a critical, yet understudied, factor in ischemic stroke.
• Further research into the mechanisms and therapeutic targeting of protein aggregation could offer new avenues for stroke treatment.
• The molecular overlap between neurodegenerative diseases and ischemic stroke, particularly concerning protein aggregation, warrants deeper exploration.